L’ECONÒMIC: The Sagrat Cor Hospital Hosts an Oncology Innovation Center for Cancer
The HUSC Oncology Innovation Cancer Center, will concentrate three interrelated activities in the same space to combat cancer: medical assistance, innovation, and a unit for clinical trials to test innovative oncological treatments and devices.
Pangaea Lab researchers innovate in liquid biopsy by using pleural fluids for molecular study and at the same time generating cell cultures to analyze the response of gastric and pancreatic cancer to drugs
The study that demonstrates this has been presented at the AACR congress and is the result of the shared leadership of the scientists of Pangaea Lab, one of the centers with the greatest expertise and experience in Spain in liquid biopsy, and IOR, leader in precision oncology.
DIARIO MÉDICO: Dr. Rafael Rosell – “Tumor cells are reprogrammed in a very efficient and intelligent way to eliminate the treatment that could destroy them”
Rafael Rosell, world expert in lung cancer. “Avoiding adaptive resistance would be the beginning of controlling tumor clinical progression, since it would control acquired resistance. A challenge in lung cancer.”
“Instituto Oncológico Dr. Rosell” & “NG Oncology” society led by Dr. Bellmunt are beginning their joint activity against cancer in Barcelona
“Instituto Oncológico Dr. Rosell” and “NG Oncology” society, led by Dr. Joaquim Bellmunt, a renowned international oncologist in bladder cancer, announce their new joint collaboration at the Hospital Universitari Sagrat Cor de Quirónsalud.
Dr. Lluís Cirera, an internationally acclaimed oncologist specializing in digestive tumors, is the head of the Oncology Department at the Hospital Universitari Sagrat Cor, where IOR has been operating since 2016.
EL CONFIDENCIAL: Doctor Javier Cortés – “It takes two years for some approved drugs to reach breast cancer patients”
Every year 6,500 women die from breast cancer in Spain and the total incidence continues to increase. We talk about the current situation of this disease with Javier Cortés, one of the leading experts in breast cancer worldwide.
EL PAÍS: The precision oncology “boutique”
Pangaea Oncology boosts growth through small acquisitions in private healthcare. Take advantage of more personalized and less toxic drugs based on the genetic profiles of each patient.
Connecting Minds and Advancing Cancer Research
We are pleased to share the success story of Anisha Jain, a PhD student from the JSS Medical Research, India. Thanks to EACR Travel Fellowship, join us at Instituto Oncológico Dr. Rosell.
HIPEC in ovarian cancer: new evidence supports its use
The decision whether or not to add HIPEC to surgery in ovarian cancer recurrence is clear: intraoperative chemotherapy increases survival without added toxicity.